Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 18, 2017
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - August 18, 2017

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

8/11/17 - "Parenteral Glucagon Formulations" in Patent Application Approval Process (USPTO 20170202926)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventor Chen, Andrew, filed on March 30, 2017, was made available online on July 27, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Latitude Pharmaceuticals, Inc.. Hypokit from Novo
8/11/17 - "Pharmaceutical Compositions of Metabotropic Glutamate 5 Receptor (Mglu5) Antagonists" in Patent Application Approval Process (USPTO 20170202819)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors Chatterji, Ashish; Huang, Jingjun; Koennings, Stephanie; Lindenstruth, Kai; Sandhu, Harpreet; Shah, Navnit, filed on January 11, 2017, was made available online on July 27, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspo
8/11/17 - "Pharmaceutical Dosage Forms" in Patent Application Approval Process (USPTO 20170202808)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors BEATO, Stefania; QUINTON, Peggy, filed on July 6, 2015, was made available online on July 27, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company or instituti
8/11/17 - Accelerating generic drug approvals will save lives and dollars
Scott Gottlieb is a little different from some of his more bureaucratic predecessors: He's listening. Last month, the commissioner of the Food and Drug Administration hosted a public meeting to solicit input from patients, care providers, and drug makers on how to improve the FDA's drug approval process and, just as importantly, expedite the introd
8/11/17 - Acceleron to Webcast Second Quarter 2017 Financial Results on August 3, 2017
By a News Reporter-Staff News Editor at Drug Week Acceleron Pharma Inc. announced it will host a webcast and conference call on Thursday, August 3, 2017 at 5:00 p.m. EDT to discuss its second quarter 2017 financial results and provide an update on recent clinical development and corporate activities. The webcast will be accessible under "Events&.
8/11/17 - Animal Health Generics 2017: Intellectual Property and Patents, Regulation Issues, Strategies for R&D and Generics Companies, Company Profiles, Industry Associates
The "Animal Health Generics 2017: Intellectual Property and Patents, Regulation Issues, Strategies for R&D and Generics Companies, Company Profiles, Industry Associates" report has been added to Research and Markets' offering.. Intellectual Property 2.1 Summary 2.2 Introduction 2.3 WIPO 2.4 Patents 2.4. 1 Types of patent 2.4. 2 Company example 2.
8/11/17 - Azurrx Biopharma, Inc. Files SEC Form S-1, General Form For Registration of Securities Under The Securities Act of 1933: (Jul. 21, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Azurrx Biopharma, Inc. was posted on July 20, 2017. The SEC file number is 0001654954-17-006580.. A U.S. Securities and Exchange Commission filing is a formal d
8/11/17 - BeiGene Announces Pricing of $175 Million Public Offering
BeiGene, Ltd., a clinical-stage biopharmaceutical company developing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, today announced the pricing of its follow-on public offering of 2,465,000 American Depositary Shares, each representing 13 of its ordinary shares, par value $0.0001 per share, at a price to th
8/11/17 - Benitec advances oculopharyngeal muscular dystrophy orphan disease programme [Algeria Press Service]
This next generation single vector system, termed BB-301, represents the clinical candidate that Benitec intends to advance into human clinical trials in the second half of calendar year 2018.. By combining both `silence and replace` functions into a single vector, Benitec can focus its manufacturing efforts for the programme on a single product, w
8/11/17 - Beta Cat Pharmaceuticals, Houston, Assigned Patent for Anthracene-9, 10-Dione Dioxime Compound Prodrugs
Beta Cat Pharmaceuticals, Houston, has been assigned a patent developed by five co-inventors for "anthracene-9, 10- dione dioxime compound prodrugs and their uses." The co-inventors are Hariprasad Vankayalapati, Draper, Utah, Xiaohui Liu, Holladay, Utah, Sunil Sharma, Salt Lake City, Srinivas Rao Kasibhatla, San Diego, and Seelam Venkata Reddy, Tel
8/11/17 - Big Data a $4 Billion Opportunity in the Healthcare and Pharmaceutical Industry; Finds New Report
Market Research Reports, Inc. has announced the addition of Big Data in the Healthcare& Pharmaceutical Industry: 2017- 2030- Opportunities, Challenges, Strategies& Forecasts research report to their website www.MarketResearchReports.comLewes, DE 08/10/2017 latest report indicates that Big Data investments in the healthcare and pharmaceu
8/11/17 - BioAxone BioSciences CEO Lisa McKerracher Accepts Role of Consortium Advisory Panelist for the Christopher Reeve Foundation [Sport360]
BioAxone BioSciences, Inc., an emerging, clinical-stage biotechnology company focused on developing innovative drugs to treat spinal cord injury and restore neurological function, today announced that CEO Lisa McKerracher has accepted an offer to join the Consortium Advisory Panel for the Christopher& Dana Reeve Foundation. The SCI community is rea
8/11/17 - Bonti Announces Topline Results of EB-001 Phase 2A Clinical Study in Glabellar Lines [Tehran Times (Iran)]
Bonti, a privately-held, clinical-stage biotechnology company, today announced topline results of the first clinical study of its lead product candidate, EB-001, in glabellar lines. The study achieved its objectives and confirmed both favorable safety and the expected clinical efficacy profile. EB-001 is a novel serotype E botulinum neurotoxin with
8/11/17 - Chiasma Reaches Agreement with FDA Under Special Protocol Assessment for a New Phase 3 Clinical Trial of Octreotide Capsules in Acromegaly [T-break Tech (Middle East)]
-Chiasma, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today announced it has reached agreement with the U.S. Food and Drug Administration on the design of a new Phase 3 clinical trial for its octreotide capsules product candidate, conditionally trade-named Mycap
8/11/17 - Commentary ? Health Care Financing: Out the roof medication costs
Yet, even though we pay more for our prescription medication than does the rest of the free world, Congress passed a law several years ago which prohibited Medicare from negotiating the price of medication directly with the pharmaceutical companies. We pay about twice as much as a citizen of Canada for Brand Name meds. Try checking your brand name
8/11/17 - Cti Biopharma Corp. Files SEC Form 3, Initial Statement of Beneficial Ownership of Securities: (Jul. 25, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Cti Biopharma Corp. was posted on July 25, 2017. The SEC file number is 0000899243-17-018916.. A U.S. Securities and Exchange Commission filing is a formal docu
8/11/17 - Cti Biopharma Corp. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Jul. 25, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Cti Biopharma Corp. was posted on July 25, 2017. The SEC file number is 0000899243-17-018917.. A U.S. Securities and Exchange Commission filing is a formal docu
8/11/17 - Cti Biopharma Corp. Files SEC Form 8-K, Current Report: (Jul. 24, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Cti Biopharma Corp. was posted on July 24, 2017. The SEC file number is 0000891293-17-000080.. A U.S. Securities and Exchange Commission filing is a formal docu
8/11/17 - CURE Pharmaceutical Enters Partnership to Distribute New Erectile Dysfuntion Drug Using Companys Proprietary CureFilm Into Asian Market [Times of Oman]
-CURE Pharmaceutical,, a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, today announced that it has partnered with a leading pharmaceutical distribution company to deliver a generic erectile dysfunction drug on its patented, multilayer oral thin film, CureFilm, into the Asian market.
8/11/17 - CUSTISPHARMA Palladino, Joshi fill out appointments
"With our recent filing of our first New Drug Application submission to the FDA, I am pleased to have Bob on my management team as our first CFO and Yatindra on our board to assist in executing our long-term growth plans," said CEO Neal Muni. He has served as CFO for 480 Biomedical, Claritas Genomics, BioNevia, Corrona, PatientsLikeMe and Biosphere
8/11/17 - Data from Northeastern University Provide New Insights into Drug Delivery Systems (Elastic liposomes as novel carriers: recent advances in drug...
The news reporters obtained a quote from the research from Northeastern University, "Increased drug encapsulation efficiency, enhanced drug permeation and penetration into or across the skin, and ultradeformability have led to widespread interest in ELs to modulate drug release, permeation, and drug action more efficiently than conventional...
8/11/17 - DrugDev and SCRS Present Educational Webinar on How to Develop an Efficient and Compliant Clinical Trial Start-Up Process [T-break Tech (Middle East)]
DrugDev and the Society for Clinical Research Sites will host a new educational webinar to demonstrate how Good Clinical Practice can be used throughout the site activation process with an emphasis on feasibility, contracts, and site documents. In 1997 the FDA ratified 13 laws for establishing GCP during clinical trials, endorsing ethics practices
8/11/17 - EDITORIAL: Trump was given a plan for easing the opioid crisis. He should follow it. [Bangor Daily News, Maine]
Aug. 10 President Donald Trump had the opportunity this week to be the strong leader that is needed to change policies and attitudes about addiction to better address the country's opioid crisis. Chris Christie, did not call for the hiring of more police officers or the construction of a border wall to reduce the flow of illegal drugs through Mex
8/11/17 - Eisai Submits Supplemental New Drug Application to FDA for Lenvatinib in First-Line Hepatocellular Carcinoma
The FDA submission is based on the positive results of the pivotal Phase 3 REFLECT trial. "Based on the activity observed in the REFLECT trial, Eisai is eager to work with the U.S. FDA and regulatory agencies worldwide with the hope of quickly bringing lenvatinib to patients with liver cancer." There is no guarantee that any investigational uses o
8/11/17 - Far Afield
I don't know if you've heard about last month's big healthcare controversy in England. An infant, less than a year old, with a rare fatal genetic disease was refused permission to come to the United States for an experimental treatment that would, at best, have added a few weeks to his tragically short life. It turned out that the American doctor h
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415